Anuh Pharma Ltd granted CEP from EDQM for Sulfadimethoxine

Anuh Pharma Limited has been granted the Certificate of Suitability (CEP) from the European Directorate for the Quality of Medicines & HealthCare (EDQM) for Sulfadimethoxine.

This approval reinforces Anuh Pharma's commitment to delivering high-quality Active Pharmaceutical Ingredients that adhere to the most stringent global regulatory standards. The CEP for Sulfadimethoxine will enable expanded access to regulated markets and support our customers with enhanced reliability, compliance, and supply security.

Shares of ANUH PHARMA LTD. was last trading in BSE at Rs. 82.55 as compared to the previous close of Rs. 79.16. The total number of shares traded during the day was 16081 in over 141 trades.

The stock hit an intraday high of Rs. 83.25 and intraday low of 79.00. The net turnover during the day was Rs. 1324268.00.

Source : Equity Bulls

Keywords

ANUHPHARMA INE489G01022 Pharmaceuticals EDQM CEP Sulfadimethoxine